Prolonged environmental exposure of arsenic through drinking water on the risk of hypertension and type 2 diabetes

Environmental Science and Pollution Research

Volumn 20, Issue 11, 2013, Pages 8151-8161

  Li, Xin ^a   Li, Bing ^a   Xi, Shuhua ^a   Zheng, Quanmei ^a   Lv, Xiuqiang ^a   Sun, Guifan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic; Arsenic metabolism; Hypertension; Type 2 diabetes; Urinary arsenic species

Indexed keywords

ARSENIC; DRINKING WATER;

ARSENIC; BLOOD; DIABETES; DRINKING WATER; GLUCOSE; HYPERTENSION; METABOLISM; PUBLIC HEALTH;

ADULT; ARTICLE; CHEMISTRY; CHINA; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; STATISTICS; WATER POLLUTANT;

ADULT; ARSENIC; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; WATER POLLUTANTS, CHEMICAL;

CHINA; NEI MONGGOL;

EID: 84885908203     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-013-1768-9     Document Type: Article

References (64)

1. Abhyankar LN, Jones MR, Guallar E, Navas-Acien A (2012) Arsenic exposure and hypertension: a systematic review. Environ Health Perspect 120: 494-500.
2. Abir T, Rahman B, D'Este C, Farooq A, Milton AH (2012) The association between chronic arsenic exposure and hypertension: a meta-analysis. J Toxicol 198793.
3. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, Gamble MV, Graziano JH (2007) Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 16: 1270-1278.
4. Bae ON, Lim EK, Lim KM, Noh JY, Chung SM, Lee MY, Yun YP, Kwon SC, Lee JH, Nah SY, Chung JH (2008) Vascular smooth muscle dysfunction induced by monomethylarsonous acid (MMA III): a contributing factor to arsenic-associated cardiovascular diseases. Environ Res 108: 300-308.
5. Beebe-Dimmer JL, Iyer PT, Nriagu JO, Keele G, Mehta S, Meliker JR, Lange EM, Schwartz AG, Zuhlke KA, Schottenfeld D, Cooney KA (2012) Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study. Environ Health 11: 43.
6. Begum M, Horowitz J, Hossain MI (2012) Low-dose risk assessment for arsenic: a meta-analysis approach. Asia Pac J Public Health (in press).
7. Buchet JP, Lauwerys R, Roels H (1980) Comparison of several methods for the determination of arsenic compounds in water and in urine. Their application for the study of arsenic metabolism and for the monitoring of workers exposed to arsenic. Int Arch Occup Environ Health 46: 11-29.
8. Chappell WR, Co A, Calderon RL, Thomas DJ (2002) Arsenic exposure and health effects V: proceedings of the Fifth International Conference on Arsenic Exposure and Health Effects, 1st edn. Elsevier, Amsterdam.
9. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, Kuo TL, Tai TY (1995) Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25: 53-60.
10. Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, Chen SY, Wu MM, Lai MS (2007a) Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol 222: 298-304.
11. Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt-Rauf P, Parvez F, van Geen A, Ahsan H (2007b) Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am J Epidemiol 165: 541-552.
12. Chen CL, Chiou HY, Hsu LI, Hsueh YM, Wu MM, Chen CJ (2010a) Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan. Environ Res 110: 455-462.
13. Chen Y, Ahsan H, Slavkovich V, Peltier GL, Gluskin RT, Parvez F, Liu X, Graziano JH (2010b) No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ Health Perspect 118: 1299-1305.
14. Chowdhury UK, Biswas BK, Chowdhury TR, Samanta G, Mandal BK, Basu GC, Chanda CR, Lodh D, Saha KC, Mukherjee SK, Roy S, Kabir S, Quamruzzaman Q, Chakraborti D (2000) Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect 108: 393-397.
15. Chung CJ, Hsueh YM, Bai CH, Huang YK, Huang YL, Yang MH, Chen CJ (2009) Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer. Cancer Causes Control 20: 1653-1661.
16. Chung CJ, Pu YS, Su CT, Huang CY, Hsueh YM (2011) Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma. Sci Total Environ 409: 465-470.
17. Coronado-González JA, Del Razo LM, García-Vargas G, Sanmiguel-Salazar F, Escobedo-de la Peña J (2007) Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ Res 104: 383-389.
18. Del Razo LM, Garcia-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, Ostrosky-Wegman P, Kelsh M, Cebrian ME (1997) Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol 71: 211-217.
19. Del Razo LM, García-Vargas GG, Valenzuela OL, Castellanos EH, Sánchez-Peña LC, Currier JM, Drobná Z, Loomis D, Stýblo M (2011) Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera Regions in Mexico. Environ Heal 10: 73.
20. Eyre H, Kahn R, Robertson RM (2004) Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. CA Cancer J Clin 54: 190-207.
21. Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51: 257-281.
22. Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, Parvez F, Levy D, Factor-Litvak P, Graziano JH (2005) Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113: 1683-1688.
23. Gribble MO, Howard BV, Umans JG, Shara NM, Francesconi KA, Goessler W, Crainiceanu CM, Silbergeld EK, Guallar E, Navas-Acien A (2012) Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am J Epidemiol 176: 865-874.
24. Heck JE, Gamble MV, Chen Y, Graziano JH, Slavkovich V, Parvez F, Baron JA, Howe GR, Ahsan H (2007) Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh. Am J Clin Nutr 85: 1367-1374.
25. Hopenhayn-Rich C, Smith AH, Goeden HM (1993) Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res 60: 161-177.
26. Hopenhayn-Rich C, Biggs ML, Kalman DA, Moore LE, Smith AH (1996) Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect 104: 1200-1207.
27. Huang YK, Tseng CH, Huang YL, Yang MH, Chen CJ, Hsueh YM (2007) Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. ToxicolApplPharmacol 218: 135-142.
28. Huang YK, Huang YL, Hsueh YM, Wang JT, Yang MH, Chen CJ (2009) Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan. Environ Health Perspect 117: 1860-1866.
29. Huang CF, Chen YW, Yang CY, Tsai KS, Yang RS, Liu SH (2011) Arsenic and diabetes: current perspectives. Kaohsiung J Med Sci 27: 402-410.
30. Islam R, Khan I, Hassan SN, McEvoy M, D'Este C, Attia J, Peel R, Sultana M, Akter S, Milton AH (2012) Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh. Environ Health 11: 38.
31. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, Rhodes CJ, Valko M (2011) Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol 31: 95-107.
32. Jones MR, Tellez-Plaza M, Sharrett AR, Guallar E, Navas-Acien A (2011) Urine arsenic and hypertension in US adults: the 2003-2008 National Health and Nutrition Examination Survey. Epidemiology 22: 153-161.
33. Kapaj S, Peterson H, Liber K, Bhattacharya P (2006) Human health effects from chronic arsenic poisoning-a review. J Environ Sci Health, Part A: Tox Hazard Subst Environ Eng 41: 2399-2428.
34. Kurttio P, Komulainen H, Hakala E, Kahelin H, Pekkanen J (1998) Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contam Toxicol 34: 297-305.
35. Li B, Sun Y, Sun X, Wang Y, Li X, Kumagai Y, Sun G (2007) Monomethylarsonous acid induced cytotoxicity and endothelial nitric oxide synthase phosphorylation in endothelial cells. Bull Environ Contam Toxicol 78: 455-458.
36. Li L, Ekström EC, Goessler W, Lönnerdal B, Nermell B, Yunus M, Rahman A, El Arifeen S, Persson LA, Vahter M (2008a) Nutritional status has marginal influence on the metabolism of inorganic arsenic in pregnant Bangladeshi women. Environ Health Perspect 116: 315-321.
37. Li X, Pi J, Li B, Xu Y, Jin Y, Sun G (2008b) Urinary arsenic speciation and its correlation with 8-OHdG in Chinese residents exposed to arsenic through coal burning. Bull Environ Contam Toxicol 81: 406-411.
38. Li X, Li B, Xu Y, Wang Y, Jin Y, Itoh T, Yoshida T, Sun G (2011) Arsenic methylation capacity and its correlation with skin lesions induced by contaminated drinking water consumption in residents of chronic arsenicosis area. Environ Toxicol 26: 118-123.
39. Lim KM, Shin YS, Kang S, Noh JY, Kim K, Chung SM, Yun YP, Chung JH (2011) Potentiation of vasoconstriction and pressor response by low concentration of monomethylarsonous acid (MMA(III)). Toxicol Lett 205: 250-256.
40. Lindberg AL, Ekstrom EC, Nermell B, Rahman M, Lonnerdal B, Persson LA, Vahter M (2008) Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ Res 106: 110-120.
41. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
42. Makris KC, Christophi CA, Paisi M, Ettinger AS (2012) A preliminary assessment of low level arsenic exposure and diabetes mellitus in Cyprus. BMC Publ Health 12: 334.
43. Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, Silbergeld EK, Styblo M, Tseng CH, Thayer KA, Loomis D (2012) Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect (in press).
44. Mitra SR, Mazumder DN, Basu A, Block G, Haque R, Samanta S, Ghosh N, Smith MM, von Ehrenstein OS, Smith AH (2004) Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect 112: 1104-1109.
45. Mukherjee A, Sengupta MK, Hossain MA, Ahamed S, Das B, Nayak B, Lodh D, Rahman MM, Chakraborti D (2006) Arsenic contamination in groundwater: a global perspective with emphasis on the Asian scenario. J Health Popul Nutr 24: 142-163.
46. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E (2008) Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300: 814-822.
47. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O (1999) Hypertension and arsenic exposure in Bangladesh. Hypertension 33: 74-78.
48. Rahman MM, Ng JC, Naidu R (2009) Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health Suppl 1: 189-200.
49. Rose GA, Blackburn H, Gillum RF, Prineas RJ (1982) Cardiovascular survey methods, 2nd edn. World Health Organization, Geneva, pp 82-85.
50. Schuhmacher-Wolz U, Dieter HH, Klein D, Schneider K (2009) Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit Rev Toxicol 39: 271-298.
51. Steinmaus C, Yuan Y, Liaw J, Smith AH (2009) Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis. Epidemiology 20: 807-815.
52. Sun G, Li X, Pi J, Sun Y, Li B, Jin Y, Xu Y (2006) Current research problems of chronic arsenicosis in China. J Health Popul Nutr 24: 176-181.
53. Sun G, Xu Y, Li X, Jin Y, Li B, Sun X (2007) Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ Health Perspect 115: 648-652.
54. Sun G, Xu Y, Zheng Q, Xi S (2011) Arsenicosis history and research progress in Mainland China. Kaohsiung J Med Sci 27: 377-381.
55. Tseng CH (2009) A review on environmental factors regulating arsenic methylation in humans. Toxicol Appl Pharmacol 235: 338-350.
56. Tseng CH, Chong CK, Heng LT, Tseng CP, Tai TY (2000a) The incidence of type 2 diabetes mellitus in Taiwan. Diabetes Res Clin Pract 50(Suppl 2): S61-S64.
57. Tseng CH, Tai TY, Chong CK, Tseng CP, Lai MS, Lin BJ, Chiou HY, Hsueh YM, Hsu KH, Chen CJ (2000b) Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 108: 847-851.
58. Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-Gonzalez MB, Garcia-Montalvo EA, Calderon-Aranda ES, Del Razo LM (2005) Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect 113: 250-254.
59. Wang SL, Chiou JM, Chen CJ, Tseng CH, Chou WL, Wang CC, Wu TN, Chang LW (2003) Prevalence of noninsulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ Health Perspect 111: 155-159.
60. Wang CH, Hsiao CK, Chen CL, Hsu LI, Chiou HY, Chen SY, Hsueh YM, Wu MM, Chen CJ (2007) A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol 222: 315-326.
61. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21: 1983-1992.
62. Xu Y, Wang Y, Zheng Q, Li X, Li B, Jin Y, Sun X, Sun G (2008) Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults. Toxicol Appl Pharmacol 232: 142-149.
63. Yoshida T, Yamauchi H, Sun G (2004) Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol Appl Pharmacol 198: 243-252.
64. Zierold KM, Knobeloch L, Anderson H (2004) Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health 94: 1936-1937.